Don’t miss the latest developments in business and finance.

USFDA removes import alert exemption status for Hydroxychloroquine Sulphate

Image
Capital Market
Last Updated : Jul 02 2020 | 11:31 AM IST
Ipca Laboratories announced that US FDA vide its e-mail dated 1 July, 2020 has intimated the company that the shortage implications for Hydroxychloroquine Sulphate has changed and that it has been removed from list of drug products in shortage and therefore, the US FDA is removing the exemption given to us from the import alert for API and formulation of Hydroxychloroquine Sulphate.

Powered by Capital Market - Live News

Disclaimer: No Business Standard Journalist was involved in creation of this content

More From This Section

First Published: Jul 02 2020 | 11:09 AM IST

Next Story